187 related articles for article (PubMed ID: 29075773)
21. Pancreatic neuroendocrine tumours in patients with von Hippel-Lindau disease.
Zwolak A; Świrska J; Tywanek E; Dudzińska M; Tarach JS; Matyjaszek-Matuszek B
Endokrynol Pol; 2020; 71(3):256-259. PubMed ID: 32797472
[TBL] [Abstract][Full Text] [Related]
22. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
23. Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
Capitanio U; Rosiello G; Erdem S; Rowe I; Kara O; Roussel E; Campi R; Klatte T; Kriegmair MC; Sibona M; Bertolo R; Ouzaid I; Mir MC; Marra G; Larcher A; Montorsi F; Salonia A;
World J Urol; 2021 Aug; 39(8):2969-2975. PubMed ID: 33416974
[TBL] [Abstract][Full Text] [Related]
24. Endocrine manifestations of von Hippel-Lindau disease.
Cassol C; Mete O
Arch Pathol Lab Med; 2015 Feb; 139(2):263-8. PubMed ID: 25611110
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
Salama Y; Albanyan S; Szybowska M; Bullivant G; Gallinger B; Giles RH; Asa S; Badduke C; Chiorean A; Druker H; Ezzat S; Hannah-Shmouni F; Hernandez KG; Inglese C; Jani P; Kaur Y; Krema H; Krimus L; Laperriere N; Lichner Z; Mete O; Sit M; Zadeh G; Jewett MAS; Malkin D; Stockley T; Wasserman JD; Xu W; Schachter NF; Kim RH
Clin Genet; 2019 Nov; 96(5):461-467. PubMed ID: 31368132
[TBL] [Abstract][Full Text] [Related]
26. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
27. von Hippel-Lindau syndrome.
Chou A; Toon C; Pickett J; Gill AJ
Front Horm Res; 2013; 41():30-49. PubMed ID: 23652669
[TBL] [Abstract][Full Text] [Related]
28. Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center.
Delman KA; Shapiro SE; Jonasch EW; Lee JE; Curley SA; Evans DB; Perrier ND
World J Surg; 2006 May; 30(5):665-9. PubMed ID: 16617420
[TBL] [Abstract][Full Text] [Related]
29. Germline mutation of von Hippel-Lindau (VHL) gene 695 G>A (R161Q) in a patient with a peculiar phenotype with type 2C VHL syndrome.
Santarpia L; Lapa D; Benvenga S
Ann N Y Acad Sci; 2006 Aug; 1073():198-202. PubMed ID: 17102087
[TBL] [Abstract][Full Text] [Related]
30. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
31. Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.
Else T; Jonasch E; Iliopoulos O; Beckermann KE; Narayan V; Maughan BL; Oudard S; Maranchie JK; Iversen AB; Goldberg CM; Fu W; Perini RF; Liu Y; Linehan WM; Srinivasan R
Clin Cancer Res; 2024 May; 30(9):1750-1757. PubMed ID: 38393723
[TBL] [Abstract][Full Text] [Related]
32. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
33. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
[TBL] [Abstract][Full Text] [Related]
34. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
[TBL] [Abstract][Full Text] [Related]
35. Germline mutations in the von Hippel-Lindau gene in Italian patients.
Ciotti P; Garuti A; Gulli R; Ballestrero A; Bellone E; Mandich P
Eur J Med Genet; 2009; 52(5):311-4. PubMed ID: 19464396
[TBL] [Abstract][Full Text] [Related]
36. Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene.
Hes F; Zewald R; Peeters T; Sijmons R; Links T; Verheij J; Matthijs G; Leguis E; Mortier G; van der Torren K; Rosman M; Lips C; Pearson P; van der Luijt R
Hum Genet; 2000 Apr; 106(4):425-31. PubMed ID: 10830910
[TBL] [Abstract][Full Text] [Related]
37. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease.
Binderup MLM; Stendell AS; Galanakis M; Møller HU; Kiilgaard JF; Bisgaard ML
Br J Ophthalmol; 2018 Jul; 102(7):942-947. PubMed ID: 28972023
[TBL] [Abstract][Full Text] [Related]
38. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
[TBL] [Abstract][Full Text] [Related]
39. High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil.
Rocha JC; Silva RL; Mendonça BB; Marui S; Simpson AJ; Camargo AA
J Med Genet; 2003 Mar; 40(3):e31. PubMed ID: 12624160
[No Abstract] [Full Text] [Related]
40. [Von Hippel-Lindau disease type 2-related pancreatic neuroendocrine tumor and adrenal myelolipoma].
Dolzhansky OV; Morozova MM; Korostelev SA; Kanivets IV; Chardarov NK; Shatveryan GA; Paltseva EM; Fedorov DN
Arkh Patol; 2016; 78(1):36-41. PubMed ID: 26978235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]